Research map: Real‐World Retrospective Analysis of Daratumumab for Relapsed or Refractory Multiple Myeloma in Regional Australia

Back to the article

Papers in this map

  1. Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR · María‐Victoria Mateos · 2019 · 159 citations · Cited by this paper
  2. Larotrectinib in Adjuvant and First‐Line Treatment for Metastatic NTRK Fusion Colon Cancer · 2026 · Related
  3. Trends in myeloma relative survival in Queensland by treatment era, age, place of residence, and socioeconomic status · Matthew Harwood · 2019 · 10 citations · Cited by this paper
  4. Mechanism of Astragalus Polysaccharides Regulating Ferroptosis and Inhibiting Malignant Progression of Ovarian Cancer Cells · 2026 · Related
  5. Patients with multiple myeloma over a large catchment of 2.5 million square kilometres: a Western Australia retrospective survival review · Teng Fong Ng · 2020 · 4 citations · Cited by this paper
  6. Evolving Trends in Laryngeal Cancer Mortality in the United States, 1999–2024: A Population‐Based Analysis With Subgroup Stratified Trends through 2020 · 2026 · Related
  7. Clinical–Pathologic Response Discordance After Neoadjuvant Therapy in Rectal Cancer and Its Prognostic Implications · 2026 · Related
  8. Epstein‐Barr Virus‐positive NK/T‐cell Malignancies in Poland: Distinctive Features, Therapeutic Strategies, and Survival Insights—The Real‐world Retrospective Report of the Polish Lymphoma Research Group · 2026 · Related
  9. Management of Adult Patients With Isocitrate Dehydrogenase‐Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro‐Oncology · 2026 · Related
  10. Extranodal (Nasal Variant) NK/T ‐Cell Lymphoma of Head and Neck: Our Experience From a Tertiary Care Centre · 2026 · Related
  11. A Japanese Multicenter Database Study of Retroperitoneal Sarcoma: Outcomes of Patients Receiving Eribulin Therapy · 2026 · Related
  12. Pan‐Cancer Analysis and Functional Characterization Identify SLC15A4 as a Novel Prognostic Biomarker and Therapeutic Target · 2026 · Related
  13. Outcomes for Patients With Micro‐Invasive or Small HER2+ Breast Cancer in Northern Sydney Local Health District · 2026 · Related

Source: OpenAlex (CC0)